by Brooke Blazr | Jan 5, 2026 | High Dispatch
Given there are serious limitations to pharmaceutical cannabinoid medications, it’s clear that the problem lies in the insurance system that has yet to evolve alongside patients’ needs and medical science. There is a clear disconnect when insurance companies...
by Brooke Blazr | Jan 4, 2026 | High Dispatch
Take cannabis, for example—my favorite barometer for societal sanity. We went from “this will literally destroy your brain and turn you into a violent criminal” to “okay maybe it’s medicine” to “actually it’s legal in half...
by Brooke Blazr | Jan 2, 2026 | High Dispatch
Dry January is no longer just a detox. What began as a post-holiday pause from drinking has evolved into a cultural reassessment of how people relax, socialize, and manage stress. Each January, millions of Americans step back from alcohol not simply to recover from...
by Brooke Blazr | Jan 2, 2026 | High Dispatch
Furthermore, Schedule III could mean that independent researchers—not just pharma shills—might finally get a seat at the table. Universities won’t have to fear losing their funding just for touching the plant. We might see a new wave of “less...
by Brooke Blazr | Jan 1, 2026 | High Dispatch
Dry January has come a long way from being a month of white-knuckled willpower and awkward soda water orders. These days, it’s less about deprivation and more about rethinking how you can socialize and still have fun while committing to a month of sobriety. This...
by Brooke Blazr | Jan 1, 2026 | High Dispatch
Well, folks, we made it through another year in the wildest timeline. 2025 was a rollercoaster ride through cannabis policy chaos, and I’ve got the whiplash to prove it. As I sit here reflecting on the year that was, I’m reminded that trying to make sense...
